Today’s AI Top Pick: BKV

7/29/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · BKV62%277 resolved forecasts · 45d window · verify →

Today's pick · Highly Shorted OversoldBKVBUY NOW8.4 / 107/29/2026

BKV is the highest-quality name in this oversold basket by a wide margin. It's the only candidate that combines a real fundamental score (8/8) with multi-timeframe forecast agreement AND clean news flow. On the tape: 1h forecasts are +20.1%/+17.2%/+16.5%, 4h are +20.4%/+24.9%/+21.9%, and 1d are +4.5%/+13.3%/+8.4% — every horizon on every timeframe is green, near_term_bullish=1.0, bullish_prob=1.0. Position in the 21-bar range is 2.53% (1h), 1.01% (4h), and 1.03% (1d) — this is deeply oversold on all timeframes, not chased, sitting near the low with drawdown -6.2%/-14.2%/-14.1%. The fundamentals are the differentiator: trailing PE 7.1, PEG 0.69, ROE 15.9%, profit margin 27.9%, sales YoY +52.4%, debt/equity 0.57, analyst recom 1.23 (Strong Buy), targetUpsidePct +43.8%. Virtually every other name in this oversold pool has negative margins, negative ROE, or three-digit ROE deficits (SERV -2640% profit margin, INV -5226%, ABAT -390%). BKV is actually profitable, growing, and cheap — a rare setup where the screen catches a solid business in a mechanical drawdown rather than a broken story. Headlines are supportive not distracting: Simply Wall St. flags '28% undervalued,' Susquehanna reiterated positive (target trim to $35 is still well above $23.51), and Q1 E&P peer comp had BKV as 'best of the bunch.' No dilution, no going-concern, no regulatory issues — contrast with REPL (FDA reviewer doubts, -32% crash), ACI (guidance cut + UBS downgrade), QCLS (license terminated), CRML (Simply Wall St. overvaluation warning), CRWV (debt concerns). Why TODAY: RSI 31.7 with a 14% multi-timeframe drawdown, a strong-buy analyst consensus, and forecasts unanimously up across 1h/4h/1d means you're getting paid to buy the fear. PSIX has bigger forecasted upside but a broken weekly (-50.8% 21-bar, weekly forecast negative). ADTN has decent fundamentals but weekly forecast is negative (-8.5% long). BKV is the only 'clean' setup where the tape, fundamentals, analyst view, and news all line up — that's rare in an oversold screen.

Entry zone

$23.20-$23.80 (buy at market or on any dip to $23.20 support)

Stop loss

$21.50 (below the 21-bar low, ~8.5% risk)

First target

$26.50 (+12.7%, aligns with 4h mid forecast and prior consolidation)

Longer target

$32-$35 (Susquehanna target zone, ~+40% consistent with analyst mean upside)

Risks

Natural gas price sensitivity — BKV is a nat-gas E&P; a further leg down in gas or WTI would pressure earnings despite the cheap 7.1 PE
Short float 20.18% is elevated — while this creates squeeze potential, it also reflects real bearish positioning
1d forecasts are the softest (fc_short only +4.5%) suggesting the daily bounce may be gradual not violent
Weekly timeframe data was missing from the candidate block — cannot confirm long-term trend structure
Debt/equity 0.57 is moderate but capex-heavy E&P model means any commodity weakness compounds fast

Honorable mentions

PSIXBest forecast magnitude in the entire pool — 1d forecasts of +94.7%/+151.9%/+144.2% with fundamental score 7.5 (PE 6.3, ROE 75.7%, profit margin 14.3%). Position 0% in 21-bar range and near_term_bullish 0.8. Downgraded to #2 because weekly forecast is NEGATIVE (-1.6%/-18.5%/-36.3%) and 21-bar weekly drawdown is -65%, suggesting structural weakness. New CEO Aug 17 is a wildcard. Better as a BUY_PULLBACK if it stabilizes.

ADTNFundamental score 5.75, PEG 0.18, fwdPe 11.57, sales YoY +18.8%, targetUpsidePct +106%. Deep drawdown (-36% on daily) and RSI 24.5 makes it oversold. But B. Riley and Needham both LOWERED targets last week and weekly forecast is negative (-8.5%/-8.9%/-8.7%) — the tape is telling you the bad news isn't priced yet.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	BKV	BUY NOW	8.4	Only name with fund score 8, all-timeframe green forecasts, deep drawdown position (~1% of range), and clean/positive news.
2	PSIX	BUY NOW	7.6	Huge daily/4h forecast (+94% to +152%) with ROE 75.7% and PE 6.3, but weekly forecast negative — size smaller.
3	ADTN	BUY PULLBACK	6.8	Cheap PEG 0.18 and RSI 24.5, but two analyst target cuts and negative weekly forecast argue for patience.
4	ARRY	BUY NOW	6.5	Near_term_bullish 1.0, fwdPe 5.62, 21-bar position 0%, weekly fc_long +108% — solar reflation trade.
5	TOYO	BUY PULLBACK	6.3	PE 4.26, PEG 0.02, ROE 46.5% is unreal but 1.56% inst-own and micro-cap $198M means it's a lottery ticket.
6	BTDR	BUY NOW	6.1	Simply Wall St. flags 43% undervalued, weekly +37.2% momentum, short float 43.35% squeeze fuel.
7	RUN	BUY NOW	6.0	PE 4.5, RSI 25.8, near_term_bullish 0.8, weekly fc_long +73% — solar oversold trade with short float 28.65%.
8	SMMT	BUY PULLBACK	5.7	CEO bought $5M own stock but going-concern flag; forecasts 1h/4h/1d positive but weekly negative.
9	ASPI	BUY NOW	5.5	Near_term_bullish 1.0, all forecasts positive short/mid, but weekly long forecast -37% caps the swing.
10	CRML	BUY PULLBACK	5.3	Rare earth narrative, +231% target upside, but Simply Wall St. flagged overvaluation and weekly fc_long +63% not enough to overcome noise.
11	ENPH	BUY PULLBACK	5.2	Profitable (PM 9.6%, ROE 14.1%) but recom 2.65 (Hold) and daily fc_short -3.6% — post-earnings mixed signals.
12	LAC	BUY PULLBACK	5.0	Deep oversold RSI 26.2, weekly drawdown -51%; all forecasts up but no revenue yet — thematic lithium hold.
13	ABAT	BUY PULLBACK	4.9	DOE grant reinstated is a real catalyst but PM -390% and weak weekly forecast (+34.7% long) doesn't inspire.
14	MP	BUY PULLBACK	4.8	US $400M stake is a positive, but SeekingAlpha downgrade and negative weekly forecast (-20.3% long) argue wait.
15	BTBT	BUY NOW	4.7	Near_term_bullish 1.0, position 68% (1h) — a bit high for a chase, but crypto beta with weekly fc_long +46.6%.
16	NRGV	BUY PULLBACK	4.6	Citi upgrade is a plus, 4h/1d forecasts up, but weekly forecasts flat and ROE -160% keeps risk high.
17	CRWV	WAIT	4.5	Big forecasts but news flow (Damodaran debt warning, neocloud financing concerns) undercuts thesis.
18	VNET	BUY PULLBACK	4.4	Near_term_bullish 1.0 and multi-tf agreement, but weekly forecast negative and D/E 7.03 is dangerous.
19	SERV	BUY PULLBACK	4.3	Huge forecast magnitude but PM -2640% and PS 69.9 is bubble-priced — pure speculation.
20	NTLA	WAIT	4.0	Position 94% (1h) is chased, Wolfe downgraded to Underperform ($9 target), weekly forecast turning negative.
21	INV	AVOID	3.8	PM -5226%, PS 76 — the fundamentals are terrifying and CEO transition adds uncertainty.
22	OKLO	WAIT	3.7	Nuclear thematic strong but no near-term forecast data provided in candidate block; wait for pullback confirmation.
23	QS	AVOID	3.6	TD Cowen cut target to $6, 52-week low, weak fundamentals, no timeframe data — broken.
24	UUUU	WAIT	3.5	Position 67% (1h) is elevated for entry, weekly forecast -40%, and daily fc_short -4% — momentum stalled.
25	LUNR	AVOID	3.4	Zacks 'Strong Sell,' weekly forecast -31%, fwdPe 3299 — extreme valuation risk despite Kronos bullish flag.
26	ACI	AVOID	3.2	Earnings miss + guidance reset + UBS downgrade — the screen caught a broken narrative post-cut.
27	PLUG	AVOID	3.0	Bankruptcy fears in headlines, PM -227%, weekly fc_short -59.3% — broken.
28	ACDC	AVOID	2.9	Recom 3.75 (near Sell), sales -18.9% YoY, negative Q1 earnings coverage — no catalyst.
29	REPL	AVOID	2.5	FDA reviewer doubts on RP1 = -32% single-day crash; advisory meeting is a binary event risk.
30	QCLS	AVOID	1.5	Terminated its own Lightsolver license, $22M market cap, bullish_prob 0, weekly forecast -100%.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord